BI Promotes Equine Gastric Health Education of Horse Owners by Vets
Boehringer Ingelheim Animal Health (BI) has put together a toolkit and video to help horse owners understand diagnosing and treating gastric ulcers.
Boehringer Ingelheim Animal Health
Boehringer Ingelheim Announces Call for Proposals for 2018 Equine Research Awards
Boehringer Ingelheim is accepting proposals for the 2018 Advancement in Equine Research Awards for Equine Respiratory Disease Research.
Outbreak Alert - Rabies
A case of rabies was recently reported in a Bobcat in Munfordville, Kentucky.
Rabies in a Kentucky Bat
Among wild animals, rabies is most often reported in skunks and raccoons but is also found in bats and foxes, and usually is transmitted from the saliva of an infected animal into a bite wound.
Boehringer Ingelheim Announces 2017 Equine Research Recipients
Boehringer Ingelheim (BI) has selected three research proposals to fund as part of its 2017 Advancement in Equine Research Award program. Since 2011 BI has given more than $470,000 to advancing the knowledge of equine infectious disease.
Boehringer Ingelheim Achieves Perfect Score for 10th Time for Workplace Equality for the LGBTQ Community
Today marks the 10th time that Boehringer Ingelheim has received a perfect score on the Corporate Equality Index (CEI) and has been designated as a 2018 Best Place to Work for LGBTQ Equality.
Boehringer Ingelheim Recognized as 'Top Employer' by Science Magazine For 13th Consecutive Year
Boehringer Ingelheim today announced it has been named to Science magazine’s annual list of “top employers” within the pharmaceutical and biotechnology industry for the 13th consecutive year. Boehringer Ingelheim was one of only 20 companies recognized.
2017 Champions of the Cause Winners Announced
Boehringer Ingelheim (BI) and EquiManagement magazine are pleased to announce this year’s Champions of the Cause Award winners, Darla Garon and Hannah Schlanger.
Boehringer Ingelheim Becomes FEI Equine Health Partner
As part of a three-year commitment, Boehringer Ingelheim has become FEI Equine Health Partner and FEI Campus Partner.
Boehringer Ingelheim Named to the 2017 Working Mother 100 Best Companies List
Boehringer Ingelheim announced today that for the sixth consecutive year it has been named to Working Mother magazine’s annual 100 Best Companies list.
Biosecurity Measures to Reduce the Spread of Equine Infectious Diseases on the Road
Travel can significantly increase the risk of a horse contracting an infectious disease.
Equine Disease Risks Remain as Summer Comes to an End
As the days get shorter and opportunities for equine activities dwindle, the immunity provided by some vaccinations administered earlier in the year may also be diminishing.
Equine Poor Performance – What’s Your Diagnosis?
Poor performance can stem from a variety of issues; however, there are a few things we know.
Boehringer Ingelheim Requests Proposals for 2017 Equine Research Awards
Boehringer Ingelheim once again invites public and private researchers studying equine infectious diseases to submit proposals for the 2017 Equine Research Awards.
Surpass (1% diclofenac sodium) Now Available
Boehringer Ingelheim Animal Health (BIAH) is pleased to announce that Surpass (1% diclofenac sodium) is back on the market after a two-year absence.
Outstanding Veterinary Technicians and Assistants Recognized with Champions of the Cause Award
Veterinary technicians and assistants play a critical role in horse health. To recognize their contributions, Boehringer Ingelheim (BI), EquiManagement magazine, and the American Association of Equine Veterinary Technicians and Assistants (AAEVT) are accepting nominations for the Champions of the Cause Award for the third year. The nomination period will run from April 17, 2017 to July 14, 2017.
